Stay updated on Acalabrutinib vs Ibrutinib in CLL Clinical Trial
Sign up to get notified when there's something new on the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page.

Latest updates to the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page
- Check4 days agoNo Change Detected
- Check10 days agoChange DetectedA minor site version update is shown (Revision: v3.4.2) and the funding-status notice has been removed as part of routine maintenance. These changes do not affect the study content or its presentation, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check17 days agoChange DetectedAdded a site-wide notice about the lapse in government funding and the NIH open status, plus a version update to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check25 days agoChange DetectedAdded a Show glossary option and new QC-related metadata (Last Update Submitted that Met QC Criteria, Last Update Posted, Revision: v3.4.0). Removed or deprecated older QC fields (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated)), No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4. No study details or content appear to be affected.SummaryDifference0.0%

- Check60 days agoChange DetectedAdded a Locations section listing study sites by state (Arizona, California, Florida, Georgia, Illinois, Kansas, Minnesota, Montana, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Texas, Virginia, Washington, Wisconsin) and updated the revision tag from v3.3.2 to v3.3.3.SummaryDifference0.9%

- Check89 days agoChange DetectedPublications section updated: new PubMed-linked publications were added on 2025-11-20 and older PubMed entries were removed on 2025-09-02 and 2025-08-29. Entries are automatically populated from PubMed and may or may not pertain to the study.SummaryDifference0.1%

Stay in the know with updates to Acalabrutinib vs Ibrutinib in CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page.